× Medicines Discovery Catapult

We can arrange media interviews and tours of our laboratory and facilities. Spokespeople, including our CEO, Chris Molloy, are available to comment on our unique approach to supporting SMEs and the discovery of new medicines.

We can also provide expert opinion and analysis on the UK government’s Industrial Strategy, the role of the NHS, SMEs, pharma and the importance of patient data in drug discovery. You can find out more about our work in the State of the Discovery Nation report.

For more information please contact our Communications Manager, Lisa Bedwell, on 01625 708395 or 07741 857132, or email media@md.catapult.org.uk

Signup to our media list to be kept up-to-date with our work and commentary and opinion on key news stories.

Medicines Discovery Catapult and LifeArc launch strategic R&D partnerships in biomarker discovery and proteomics technology

Today (9th May 2019), Medicines Discovery Catapult and LifeArc, leading forces driving UK innovation in drug discovery, announce their strategic partnership. The identification and development of novel biomarkers that detect efficacy and safety of novel drug molecules, which can be used in human trials, will be the focus of the partnership. LifeArc has a growing […]

Read more

NC3Rs Technologies to Tools (T2T) award winners announced

Accelerating translation of more predictive cell models in drug discovery Today (7th May 2019), the National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs) and Medicines Discovery Catapult announce the winners of the NC3Rs Technologies to Tools (T2T) awards. The T2T awards support the translation of non-animal in vitro models and technologies into […]

Read more

‘Pay as you go’ Artificial Intelligence

Chief.AI and Medicines Discovery Catapult awarded funding to make AI accessible to all drug discovery researchers Today (1st May 2019), Artificial Intelligence (AI) in drug discovery gains further support as Chief.AI and Medicines Discovery Catapult secure a grant from Innovate UK to make AI accessible to all drug discovery researchers. This partnership will address the […]

Read more

Leveraging the UK’s renowned contract research sector to boost industrial growth

Medicines Discovery Catapult’s Virtual R&D Discovery Services platform announce twenty-two partnerships Today (26th April 2019), Medicines Discovery Catapult announces the launch of twenty-two partnerships with UK contract research organisations (CROs). The aim is to boost UK life sciences R&D and international competitiveness by channelling high quality projects through best-in-class service providers. These world-class CROs join […]

Read more

Unrivalled imaging capabilities now available to accelerate UK drug development

Medicines Discovery Catapult integrates Alderley Park’s imaging services and expertise, further enhancing pre-clinical imaging capabilities Today (9th April 2019), Medicines Discovery Catapult has agreed with Alderley Park Ltd to integrate Alderley Park’s imaging services and expertise into their pre-clinical imaging capability, further enhancing their offering to UK SMEs. Medicines Discovery Catapult will now offer collaborative […]

Read more

EPSRC announces 75 new Centres for Doctoral Training

The Engineering and Physical Sciences Research Council (EPSRC) has awarded a total of £446 million in funding for 75 new Centres for Doctoral Training (CDTs) to address UK skills needs at the doctoral level. In total, 354 proposals were submitted from 73 institutions, the value of all proposals submitted was around £1.9 billion. Congratulations to […]

Read more

NHS Long Term Plan: making the NHS fit for the future

As medicine advances, health needs change and society develops, the NHS has to continually move forward so that in 10 years time we have a service fit for the future. Yesterday, the NHS launched it’s Long Term Plan designed to do just that. Our Chief Executive, Chris Molloy, provided an exclusive comment to Pharmafield: “The […]

Read more

£1.3 billion investment in UK economy as UK Government publishes second Life Sciences Sector Deal

Today (5th December 2018) we were delighted to attend the launch of the UK Governments’ second Life Sciences Sector Deal. The deal included major investments totalling £1.3 billion in the UK economy and the launch of a new collaboration between government and industry to drive early disease detection. Accelerating Detection of Disease will collect data from […]

Read more

Research Showcase launches new collaboration to accelerate translation of more predictive research models in drug discovery

Medicines Discovery Catapult and the National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs) announce strategic collaboration to accelerate the translation of more predictive in vitro research models into new products and services Today (9th November 2018) Medicines Discovery Catapult and the NC3Rs have announced a strategic collaboration combining research and […]

Read more